NOW OFFERING COVID 19 RAPID ANTIGEN TEST

Get Healthy!

Depression Might Sometimes Be Early Sign of Alzheimer's Disease
  • Posted August 30, 2024

Depression Might Sometimes Be Early Sign of Alzheimer's Disease

In some people, new-onset depression may stem from the same buildup of toxic plaques in the brain that have long been linked to Alzheimer's disease, according to a new study.

"Our findings provide additional support for depressive symptoms as an early feature of preclinical Alzheimer's disease," wrote a team led by Catherine Munro. She's a neuropsychologist at Brigham and Women's Hospital in Boston. 

"It's not that depression caused Alzheimer's disease, it's just that Alzheimer's disease pathology affecting this part of the brain resulted in depressive symptoms relatively early on in the course," explained another expert, Dr. Marc Gordon, who wasn't involved in the study.  

He's chief of neurology at Northwell's Zucker Hillside Hospital in Great Neck, N.Y.

As the Boston researchers point out, "neuropsychiatric symptoms, particularly depression, are common in Alzheimer disease."  But the exact links between depression and Alzheimer's have been unclear.

In the new study, Munro and colleagues tracked rates of depressive symptoms in 154 people enrolled in the ongoing Harvard Aging Brain Study. 

All were mentally unimpaired as they joined the study, and data were collected between 2010 and 2022.  That data included the results of PET scans taken of each patient's brain once every two to three years for an average of just under nine years.  

Those scans looked for the accumulation of amyloid protein plaques within brain tissues -- a known hallmark of Alzheimer's disease.

Among people who had either mild depressive symptoms or none when they entered the study, "increasing depressive symptoms were associated with early amyloid accumulation in brain regions involved in emotional control," Munro's group reported. 

They note that this link between depression and amyloid buildup occurred whether or not troubles with memory or thinking had already begun to appear.

According to Gordon, the new data help clear up some confusion around links between depression and Alzheimer's disease.

"I think in the past this may have been misconstrued sometimes as what was called 'pseudo depression' –- that people who had cognitive impairments appeared to have symptoms that might mimic depression," he explained. "But I think it's become evident that depression may be a very early manifestation of the disease."

In other words, folks aren't always becoming depressed as a result of having mental difficulties tied to Alzheimer's -- their depression might be linked to the same underlying amyloid buildup associated with Alzheimer's.

"I think this paper demonstrates that the actual neuropathology of disease in certain parts of the brain may be what's driving the relatively early presentation of depressive symptoms, independent of cognitive symptoms," Gordon said.

According to Munro's team, these insights could identify depression as a potential sign of Alzheimer's in at-risk people -- one that arises prior to cognitive difficulties. 

They note that early detection of Alzheimer's is becoming more important in an era where newly approved drugs can help slow the illness.

According to Gordon, there's even the possibility that these drugs, targeted at amyloid, might curb cognitive decline plus any emotional/behavior issues, such as depression.  

However, he stressed that all this research is in an early stage so "we don't know that yet," for sure.

The Boston researchers agreed that depressive symptoms might someday become part of the checklist for diagnosing Alzheimer's.

The findings "underscore the importance of monitoring new and increasing affective [emotional] symptoms in addition to cognitive changes in older adults presenting in psychiatry clinics and when screening for Alzheimer's disease," they said.

The findings were published Aug. 29 in JAMA Network Open.

More information

Find out more about the role of amyloid plaques in Alzheimer's disease at the National Institute on Aging.

SOURCES: Marc Gordon, MD, chief of neurology, Northwell Health Zucker Hillside Hospital, Great Neck, N.Y.; JAMA Network Open, Aug. 29, 2024

HealthDay
Health News is provided as a service to Pacific Medical Pharmacy #2 site users by HealthDay. Pacific Medical Pharmacy #2 nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags